Matthew Albert

USPTO Trademark & Patent Filings

Trademark applications and grants for Matthew Albert. Matthew Albert has 3 trademark applications. The latest application filed is for "a symbol or image mark"

Company Profile

Matthew Albert
matthew albert
ALBERT; Matthew - Paris FR
Albert; Matthew - Scarborough CA
Albert; Matthew - Hollis NH
Albert; Matthew - Paris FR

Entity Type	INDIVIDUAL
Address	1638 Sideboats Ct. Chesterfield, MISSOURI UNITED STATES 63005

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY 20220117960 - 17/551379 BARREIRA DA SILVA; Rosa ; et al.	2022-04-21
ROOFING GUARD FOR CARPENTERS 20210017777 - 16/516446 Albert; Rino P. ; et al.	2021-01-21
DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTH 20200268859 - 15/930166 BARREIRA DA SILVA; Rosa ; et al.	2020-08-27
Automated Cryogenic Storage And Retrieval System 20190293344 - 16/354993 Sun; Lingchen ; et al.	2019-09-26
DIPEPTIDYLPEPTIDASE 4 INHIBITION ENHANCES LYMPHOCYTE TRAFFICKING, IMPROVING BOTH NATURALLY OCCURRING TUMOR IMMUNITY AND IMMUNOTHERAPY 20180228881 - 15/750098 BARREIRA DA SILVA; Rosa ; et al.	2018-08-16
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy 11,229,645 - 15/930,166 Barreira Da Silva , et al. January 25, 2	2022-01-25
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy 11,000,521 - 15/750,098 Barreira Da Silva , et al. May 11, 2	2021-05-11
Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS 10,254,282 - 15/339,137 Muller-Trutwin , et al.	2019-04-09
Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS 9,523,687 - 14/193,835 Muller-Trutwin , et al. December 20, 2	2016-12-20
Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess clearance of infection, response to interferon therapy, and treating chronic infections 8,124,332 - 12/533,388 Albert , et al. February 28, 2	2012-02-28

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"Symbol/Image" 88893746	Symbol/Image 2020-04-29
"BAKESY" 88756931	BAKESY 2020-01-13
"PURPLE DUCK BAKING" 5574730 87793181	PURPLE DUCK BAKING 2018-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.